Immune-checkpoint inhibitor resistance in patients with cancer
The introduction of immune checkpoint inhibitors (ICIs) has transformed the landscape of oncology, offering significant improvements in patient survival and achieving remarkable long-term outcomes. Despite these advances, the therapeutic benefits of ICIs are not universal, and existing biomarkers of...
Saved in:
| Main Authors: | Luis Cabezón-Gutiérrez, Sara Custodio-Cabello, Magda Palka-Kotlowska, Beatriz Chacón-Ovejero, Vilma Pacheco-Barcia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-05-01
|
| Series: | Exploration of Immunology |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1003196/1003196.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors
by: Jiyuan Yang, et al.
Published: (2025-08-01) -
Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
by: Yanmei Liu, et al.
Published: (2025-08-01) -
Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma
by: Fen Liu, et al.
Published: (2025-08-01) -
Anti-tumor effects of recombinant human cyclophilin A combined with immune checkpoint inhibitors in the experimental model of melanoma B16 in vivo
by: A. A. Kalinina, et al.
Published: (2024-10-01) -
Research progress of immune checkpoint inhibitors in the treatment of acral melanoma
by: QIAN Jiajia, RUAN Cong, LIU Jiyong, XU Rui
Published: (2025-07-01)